Skip to main content
. 2021 Feb 1;28:1073274821989321. doi: 10.1177/1073274821989321

Table 1.

Characteristics of SCCE Patients From the SEER Database.

SCCE Non-SCCE χ2 P value
Age 18.36 <0.001
<70 years 191(50.26%) 8634(21.37%)
≥70 years 189(49.74%) 31767(78.63%)
Race 2.36 0.31
White 302(79.47%) 27453(86.61%)
Black 52(13.68%) 2576(8.13%)
Other 26(6.84%) 1668(5.26%)
Sex
Male 235(61.84%) 22573(71.06%) 1.82 0.23
Female 145(38.16%) 9194(28.94%)
Stage 8.03 0.04
Localized 64(16.84%) 15411(21.89%)
Regional 66(17.37%) 21054(29.91%)
Distant 196(51.58%) 23613(33.54%)
Unknown 54(14.21%) 10323(14.66%)
Surgery
Yes 32(8.42%) 17307(24.58%) 9.07 0.004
No/Unknown 338(91.95%) 53094(75.41%)
Chemotherapy
Yes 259(68.16%) 38759(55.06%) 3.57 0.08
No/Unknown 121(31.84%) 31642(44.94%)
Radiotherapy
Yes 162(42.63%) 36873(52.38%) 1.62 0.26
No/Unknown 218(57.37%) 33528(47.62%)

SCCE, small-cell carcinoma of the esophagus; SEER, Surveillance, Epidemiology, and End Results.